CD8A and diabetes mellitus: Consistent with this, it has been shown that when compared to healthy controls, CD8+ T cells from patients with diabetes had reduced lysis of target cells (143), and using genome-wide expression analysis of PBMCs from donors with diabetes showed a reduction in activity of cytotoxic genes compared to controls (144).